SCHEMBL5000806

SCHEMBL5000806

NC(c1cncc(-c2ccc(F)cc2F)n1)c1ccco1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3R1 P27986 1/20 0.38
PIK3CA P42336 1/20 0.38
ALOX5AP P20292 6/20 0.37
FEN1 P39748 6/20 0.37
KMO O15229 1/20 0.34
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
PLK4 O00444 1/20 0.31
AURKA O14965 1/20 0.31
MAPK13 O15264 1/20 0.31
DAPK3 O43293 1/20 0.31
ROCK2 O75116 1/20 0.31
CHEK2 O96017 1/20 0.31
CDK1 P06493 1/20 0.31
CSF1R P07333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4990889 0.77 PIK3R1 (0.51) PIK3R1PIK3CAKMOADORA2AADORA1
SCHEMBL4994019 0.72 NPC1 (0.41) IRAK4ALDH1A1KDM4EMEN1USP2
SCHEMBL5003121 0.71 GRM4 (0.44) ALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL5000809 0.70 FYN (0.52) ALDH1A1GAAKDM4EMEN1USP2
SCHEMBL28202407 0.62 PIK3R1 (0.56) PIK3R1PIK3CAADORA2AL3MBTL1ALDH1A1
SCHEMBL13261826 0.62 KMO (0.51) KMOADORA2AADORA1L3MBTL1CASP3
SCHEMBL2609356 0.62 KMO (0.42) KMOADORA2AADORA1L3MBTL1CASP3
SCHEMBL4021049 0.61 KMT2A (0.44) L3MBTL1ALDH1A1KDM4EMEN1USP2
SCHEMBL4028337 0.60 ALOX5AP (0.54) ALOX5APFEN1KMOL3MBTL1CASP3
SCHEMBL2323758 0.60 ADORA2A (0.44) ALOX5APFEN1KMOADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194574-A1 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases AXXIMA PHARMACEUTICALS AG (DE) 2008-08-14 US claimed
EP-1694670-A1 PYRAZINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES GPC Biotech AG (DE) 2006-08-30 EP claimed
WO-2005058876-A1 PYRAZINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES GPC BIOTECH AG (DE) 2005-06-30 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194574-A1 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases PRNP, PSEN1, PPP5C PIK3R1 3081/4885PIK3CA 2921/4885ALOX5AP 3465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.